The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
Conditions
Ulcerative Colitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Seventh Medical Center, PLA General Hospital, Beijing, Beijing Municipality, China
Chongqing General Hospital, Chongqing, Chongqing Municipality, China
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Contact: Study coordinator (Ping An, PhD)The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China
2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Huzhou City Central Hospital, Huzhou, Zhejiang, China
Contact: Study coordinator (ChunYan Liu, MD)Jinhua City Central Hospital, Jinhua, Zhejiang, China
Contact: Study coordinator (Qunying Wang)Quzhou City People's Hospital, Quzhou, Zhejiang, China
Contact: Study coordinator (Quanzhong Ye)The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China
Contact: Study coordinator (Yi Jiang, MD)